Literature DB >> 20101001

Carotid baroreceptor stimulation, sympathetic activity, baroreflex function, and blood pressure in hypertensive patients.

Karsten Heusser1, Jens Tank, Stefan Engeli, André Diedrich, Jan Menne, Siegfried Eckert, Tim Peters, Fred C G J Sweep, Hermann Haller, Andreas M Pichlmaier, Friedrich C Luft, Jens Jordan.   

Abstract

In animals, electric field stimulation of carotid baroreceptors elicits a depressor response through sympathetic inhibition. We tested the hypothesis that the stimulation acutely reduces sympathetic vasomotor tone and blood pressure in patients with drug treatment-resistant arterial hypertension. Furthermore, we tested whether the stimulation impairs the physiological baroreflex regulation. We studied 7 men and 5 women (ages 43 to 69 years) with treatment-resistant arterial hypertension. A bilateral electric baroreflex stimulator at the level of the carotid sinus (Rheos) was implanted > or =1 month before the study. We measured intra-arterial blood pressure, heart rate, muscle sympathetic nerve activity (microneurography), cardiac baroreflex sensitivity (cross-spectral analysis and sequence method), sympathetic baroreflex sensitivity (threshold technique), plasma renin, and norepinephrine concentrations. Measurements were performed under resting conditions, with and without electric baroreflex stimulation, for > or =6 minutes during the same experiment. Intra-arterial blood pressure was 193+/-9/94+/-5 mm Hg on medications. Acute electric baroreflex stimulation decreased systolic blood pressure by 32+/-10 mm Hg (range: +7 to -108 mm Hg; P=0.01). The depressor response was correlated with a muscle sympathetic nerve activity reduction (r(2)=0.42; P<0.05). In responders, muscle sympathetic nerve activity decreased sharply when electric stimulation started. Then, muscle sympathetic nerve activity increased but remained below the baseline level throughout the stimulation period. Heart rate decreased 4.5+/-1.5 bpm with stimulation (P<0.05). Plasma renin concentration decreased 20+/-8% (P<0.05). Electric field stimulation of carotid sinus baroreflex afferents acutely decreased arterial blood pressure in hypertensive patients, without negative effects on physiological baroreflex regulation. The depressor response was mediated through sympathetic inhibition.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20101001     DOI: 10.1161/HYPERTENSIONAHA.109.140665

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  116 in total

Review 1.  Carotid baroreceptor activation for the treatment of resistant hypertension and heart failure.

Authors:  Michael Doumas; Charles Faselis; Costas Tsioufis; Vasilios Papademetriou
Journal:  Curr Hypertens Rep       Date:  2012-06       Impact factor: 5.369

Review 2.  Under pressure: the search for the essential mechanisms of hypertension.

Authors:  Thomas M Coffman
Journal:  Nat Med       Date:  2011-11-07       Impact factor: 53.440

Review 3.  Detection and treatment of resistant hypertension.

Authors:  Julian Segura; Alejandro de la Sierra; Luis M Ruilope
Journal:  Curr Hypertens Rep       Date:  2010-10       Impact factor: 5.369

4.  Does our fat tell our brain what to do? A sympathetic' appraisal.

Authors:  Gregory D Fink
Journal:  J Physiol       Date:  2010-05-01       Impact factor: 5.182

Review 5.  New therapeutic approaches to resistant hypertension.

Authors:  Markus P Schlaich; Henry Krum; Murray D Esler
Journal:  Curr Hypertens Rep       Date:  2010-08       Impact factor: 5.369

6.  Comments on Point:Counterpoint: The dominant contributor to systemic hypertension: Chronic activation of the sympathetic nervous system vs. Activation of the intrarenal renin-angiotensin system. Activated intrarenal renin-angiotensin system is correlated with high blood pressure in humans.

Authors:  Hiroyuki Kobori; Qi Fu; Steven D Crowley; Romer A Gonzalez-Villalobos; Ruy R Campos
Journal:  J Appl Physiol (1985)       Date:  2010-12

Review 7.  Premise, promise, and potential limitations of invasive devices to treat hypertension.

Authors:  Elizabeth A Martin; Ronald G Victor
Journal:  Curr Cardiol Rep       Date:  2011-02       Impact factor: 2.931

Review 8.  Neurocardiology: therapeutic implications for cardiovascular disease.

Authors:  David S Goldstein
Journal:  Cardiovasc Ther       Date:  2010-11-25       Impact factor: 3.023

9.  [Resistant hypertension : What is it?].

Authors:  F C Luft
Journal:  Internist (Berl)       Date:  2015-03       Impact factor: 0.743

Review 10.  Device-based therapies for arterial hypertension.

Authors:  Lucas Lauder; Michel Azizi; Ajay J Kirtane; Michael Böhm; Felix Mahfoud
Journal:  Nat Rev Cardiol       Date:  2020-04-14       Impact factor: 32.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.